nucleusRx Inc
This Study will be performed with fifteen (15) Heart Failure (HF) patients for remote monitoring of health and medication adherence following hospital discharges. Participants will be enrolled into two groups: Group 1 (chronic) will be enrolled on Day 30 to 180 post hospital discharge and monitored for 30 days; Group 2 (Acute) will be enrolled on Day 1-3 of hospital discharge after recent HF episodes and monitored for 30 days. Each participant will receive a Pill Dispenser being developed by the study sponsor, a BP machine, a weighing scale and a smartphone loaded with the software developed by the study sponsor that can collect and summarize participant's health data for study physician's/nurse's evaluation. Both BP machine and weighing scale record participant's data automatically to send to the study team physician/nurse for evaluation of his/her health. Outpatient pharmacy will deliver 30 days (+7) of medications as prescribed by the patient's physician in the standard pharmacy vials, and the patients will procure them from their chosen pharmacy outlet. Prescription details for medications will also be sent to the participant's mobile phone. Medications will be uploaded in the dispenser on Day 1 by the patient in presence of a visiting nurse (a member of the study team) who will review and explain medication records with the patient. Nurse will also review and set up the machine as necessary for the daily wellness parameters to be measured and entered by the patient. Data will be collected automatically for the length of the study (30 days). A 24-hr telephone number will be available to each patient to contact study nurse for any issues related to medication dispensing and/or health. Devices will be returned to the study investigator on Day 30 and the remaining pills in the pill dispenser will be manually counted by the study nurse in both groups for comparing against the automatically collected data.
Overview of Study Design Heart Failure patients will be studied in two groups: Group 1 (Chronic): Patients who were hospitalized for heart failure 30 to 180 days ago will be enrolled into the study and monitored at-home using NRX platform for 30 days Group 2 (Acute): Patients who are hospitalized after an acute heart attack will be monitored using NRX platform at home for 30 days within 72 hr of hospital discharge. Patients in Group 1 will visit the clinic on Day 1 and Day 30 of the study for baseline and final study day data collection, respectively. Patients in Group 2 will make clinic v…
Inclusion Criteria: 1. Objectively confirmed heart failure (HF) 2. Group 1 (chronic): Hospitalized within last one to six months Group 2 (acute): within 72 hour of hospital discharge Both groups have new onset heart failure with hospitalization for the first time 3. The participating patient must have the physical and mental capacity to be trained to use the study medication dispensing device, BP, scale and use them correctly and operate the smart phone/tablet to answer questions related to the disease symptoms. 4. Age range: from 18 to 89 years 5. Patient seen by Clinical Cardiology team dur…
The embedded software of the device connects with the patient's electronic health record (EHR) and provider's dashboard system to collect prescription information and control the dispenser through an interactive Q\&A with patient's mobile phone. Patient/caregiver is trained to be reminded of the programmed medication or dose changes through the device voice prompt and/or notifications on the NRX mobile phone app. The changed medication or its dose as requested by the investigator will be dispensed from the NRX dispenser following an authentication by the patient.